 Sara Johnson
Concepts (154)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Blueberry Plants | 2 | 2023 | 4 | 1.700 |
Why?
| | Gastrointestinal Microbiome | 7 | 2025 | 640 | 1.520 |
Why?
| | Brassica | 1 | 2025 | 5 | 0.950 |
Why?
| | Beta vulgaris | 1 | 2025 | 11 | 0.940 |
Why?
| | Dietetics | 1 | 2023 | 22 | 0.840 |
Why?
| | Mindfulness | 5 | 2023 | 116 | 0.820 |
Why?
| | Diet | 3 | 2025 | 1213 | 0.780 |
Why?
| | Plaque, Atherosclerotic | 1 | 2022 | 55 | 0.760 |
Why?
| | Cardiovascular System | 1 | 2023 | 136 | 0.760 |
Why?
| | Cardiovascular Diseases | 2 | 2023 | 2006 | 0.720 |
Why?
| | Atherosclerosis | 1 | 2022 | 402 | 0.590 |
Why?
| | Hypertension | 2 | 2023 | 1243 | 0.530 |
Why?
| | RNA-Binding Proteins | 2 | 2011 | 387 | 0.530 |
Why?
| | Saccharomyces cerevisiae Proteins | 2 | 2011 | 383 | 0.520 |
Why?
| | Nuclear Proteins | 2 | 2011 | 660 | 0.480 |
Why?
| | RNA, Messenger | 2 | 2011 | 2708 | 0.400 |
Why?
| | RNA, Fungal | 1 | 2011 | 67 | 0.370 |
Why?
| | RNA Processing, Post-Transcriptional | 1 | 2011 | 87 | 0.350 |
Why?
| | Phenols | 2 | 2023 | 96 | 0.320 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2023 | 2442 | 0.320 |
Why?
| | Insulin Resistance | 3 | 2022 | 1167 | 0.310 |
Why?
| | RNA 3' End Processing | 1 | 2008 | 11 | 0.310 |
Why?
| | mRNA Cleavage and Polyadenylation Factors | 1 | 2008 | 27 | 0.310 |
Why?
| | Mental Health | 2 | 2025 | 688 | 0.270 |
Why?
| | Saccharomyces cerevisiae | 1 | 2011 | 530 | 0.270 |
Why?
| | Feces | 3 | 2025 | 442 | 0.270 |
Why?
| | Anthocyanins | 2 | 2024 | 31 | 0.270 |
Why?
| | Double-Blind Method | 4 | 2025 | 1875 | 0.260 |
Why?
| | Gastrointestinal Tract | 2 | 2021 | 186 | 0.260 |
Why?
| | Cross-Over Studies | 2 | 2025 | 520 | 0.250 |
Why?
| | Gastrointestinal Diseases | 2 | 2025 | 198 | 0.240 |
Why?
| | Microalgae | 1 | 2025 | 9 | 0.240 |
Why?
| | Sambucus | 1 | 2024 | 1 | 0.230 |
Why?
| | Fruit and Vegetable Juices | 1 | 2024 | 14 | 0.230 |
Why?
| | Postmenopause | 2 | 2023 | 349 | 0.220 |
Why?
| | Dietary Supplements | 2 | 2025 | 534 | 0.210 |
Why?
| | Powders | 1 | 2023 | 43 | 0.210 |
Why?
| | Mice, Knockout, ApoE | 1 | 2022 | 11 | 0.200 |
Why?
| | Fruit | 1 | 2023 | 133 | 0.200 |
Why?
| | Apolipoproteins E | 1 | 2022 | 77 | 0.200 |
Why?
| | Ascorbic Acid | 1 | 2023 | 120 | 0.200 |
Why?
| | Fragaria | 1 | 2021 | 2 | 0.190 |
Why?
| | Bile Acids and Salts | 1 | 2023 | 195 | 0.190 |
Why?
| | Polyphenols | 1 | 2021 | 18 | 0.190 |
Why?
| | B-Lymphocyte Subsets | 1 | 2002 | 74 | 0.190 |
Why?
| | Osteoporosis, Postmenopausal | 1 | 2021 | 39 | 0.190 |
Why?
| | Dietary Fats | 1 | 2023 | 301 | 0.180 |
Why?
| | Feasibility Studies | 1 | 2025 | 869 | 0.180 |
Why?
| | Bulimia | 1 | 2020 | 23 | 0.180 |
Why?
| | Binge-Eating Disorder | 1 | 2020 | 16 | 0.180 |
Why?
| | Humans | 17 | 2025 | 129625 | 0.170 |
Why?
| | Bacillus subtilis | 1 | 2021 | 65 | 0.170 |
Why?
| | Probiotics | 1 | 2021 | 51 | 0.170 |
Why?
| | Feeding and Eating Disorders | 1 | 2022 | 147 | 0.170 |
Why?
| | Mentors | 1 | 2022 | 177 | 0.170 |
Why?
| | Fatty Acids | 1 | 2023 | 427 | 0.170 |
Why?
| | Antigens | 1 | 2002 | 356 | 0.170 |
Why?
| | Immunomodulation | 1 | 2021 | 92 | 0.170 |
Why?
| | Plant Extracts | 1 | 2021 | 199 | 0.160 |
Why?
| | Glucose Intolerance | 1 | 2021 | 142 | 0.160 |
Why?
| | Female | 14 | 2025 | 68734 | 0.150 |
Why?
| | Obesity | 5 | 2024 | 2882 | 0.150 |
Why?
| | Leukocytes, Mononuclear | 1 | 2021 | 546 | 0.150 |
Why?
| | Vascular Diseases | 1 | 2021 | 240 | 0.140 |
Why?
| | Bone Density | 1 | 2021 | 463 | 0.140 |
Why?
| | Biomarkers | 3 | 2025 | 3968 | 0.140 |
Why?
| | Anti-Inflammatory Agents | 1 | 2021 | 482 | 0.140 |
Why?
| | Students | 1 | 2022 | 582 | 0.130 |
Why?
| | Ethinyl Estradiol | 1 | 2016 | 17 | 0.130 |
Why?
| | Aging | 2 | 2008 | 1778 | 0.130 |
Why?
| | Endothelium, Vascular | 1 | 2023 | 903 | 0.130 |
Why?
| | Peromyscus | 1 | 2016 | 28 | 0.130 |
Why?
| | Health Behavior | 1 | 2022 | 743 | 0.130 |
Why?
| | Oxidative Stress | 1 | 2023 | 1266 | 0.130 |
Why?
| | Benzhydryl Compounds | 1 | 2016 | 66 | 0.130 |
Why?
| | Adult | 9 | 2025 | 35599 | 0.130 |
Why?
| | Blood Pressure | 1 | 2023 | 1736 | 0.120 |
Why?
| | Animals | 6 | 2023 | 35391 | 0.120 |
Why?
| | Inflammation | 2 | 2023 | 2750 | 0.120 |
Why?
| | Male | 12 | 2025 | 63670 | 0.120 |
Why?
| | Healthy Volunteers | 2 | 2025 | 201 | 0.100 |
Why?
| | Middle Aged | 5 | 2025 | 31136 | 0.100 |
Why?
| | Mice | 4 | 2022 | 16961 | 0.090 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2011 | 132 | 0.090 |
Why?
| | Hydrolysis | 1 | 2011 | 186 | 0.090 |
Why?
| | Adolescent | 7 | 2023 | 20412 | 0.090 |
Why?
| | Disease Models, Animal | 2 | 2021 | 4078 | 0.090 |
Why?
| | B-Lymphocytes | 2 | 2008 | 816 | 0.080 |
Why?
| | RNA, Untranslated | 1 | 2011 | 118 | 0.080 |
Why?
| | Bacteria | 1 | 2016 | 814 | 0.080 |
Why?
| | Risk Factors | 1 | 2023 | 9786 | 0.080 |
Why?
| | Overweight | 2 | 2024 | 531 | 0.080 |
Why?
| | RNA Transport | 1 | 2008 | 23 | 0.080 |
Why?
| | Weight Gain | 2 | 2023 | 509 | 0.080 |
Why?
| | Active Transport, Cell Nucleus | 1 | 2008 | 113 | 0.070 |
Why?
| | Aged | 2 | 2025 | 22061 | 0.070 |
Why?
| | Pilot Projects | 2 | 2025 | 1592 | 0.070 |
Why?
| | Ribonucleoproteins | 1 | 2008 | 87 | 0.070 |
Why?
| | Adenosine Triphosphatases | 1 | 2008 | 161 | 0.070 |
Why?
| | Cellular Senescence | 1 | 2008 | 181 | 0.070 |
Why?
| | United States | 1 | 2023 | 13871 | 0.060 |
Why?
| | Binding Sites | 1 | 2008 | 1248 | 0.060 |
Why?
| | Stress, Psychological | 2 | 2025 | 1068 | 0.060 |
Why?
| | Hematopoietic Stem Cells | 1 | 2008 | 382 | 0.060 |
Why?
| | Amino Acid Sequence | 1 | 2008 | 2057 | 0.060 |
Why?
| | Molecular Sequence Data | 1 | 2008 | 2835 | 0.060 |
Why?
| | Hyperphagia | 1 | 2023 | 34 | 0.050 |
Why?
| | Body Mass Index | 2 | 2021 | 2274 | 0.050 |
Why?
| | Immunoglobulin delta-Chains | 1 | 2002 | 2 | 0.050 |
Why?
| | Immunoglobulin mu-Chains | 1 | 2002 | 9 | 0.050 |
Why?
| | Immunoglobulin Idiotypes | 1 | 2002 | 27 | 0.050 |
Why?
| | Genes, Immunoglobulin | 1 | 2002 | 28 | 0.050 |
Why?
| | Young Adult | 3 | 2025 | 12455 | 0.050 |
Why?
| | Leukocyte Common Antigens | 1 | 2002 | 82 | 0.050 |
Why?
| | Immunoglobulin Heavy Chains | 1 | 2002 | 80 | 0.050 |
Why?
| | Lymphopenia | 1 | 2002 | 60 | 0.050 |
Why?
| | Lymphocyte Count | 1 | 2002 | 148 | 0.050 |
Why?
| | Models, Biological | 1 | 2008 | 1724 | 0.050 |
Why?
| | Bone Resorption | 1 | 2021 | 80 | 0.050 |
Why?
| | Germ-Free Life | 1 | 2021 | 33 | 0.040 |
Why?
| | Immunophenotyping | 1 | 2002 | 311 | 0.040 |
Why?
| | Oxidation-Reduction | 1 | 2024 | 1028 | 0.040 |
Why?
| | Immunoglobulin M | 1 | 2002 | 276 | 0.040 |
Why?
| | Spleen | 1 | 2002 | 509 | 0.040 |
Why?
| | Surveys and Questionnaires | 2 | 2022 | 5415 | 0.040 |
Why?
| | Parent-Child Relations | 1 | 2022 | 259 | 0.040 |
Why?
| | Universities | 1 | 2022 | 409 | 0.040 |
Why?
| | Mentoring | 1 | 2022 | 128 | 0.040 |
Why?
| | Up-Regulation | 1 | 2002 | 840 | 0.040 |
Why?
| | Parenting | 1 | 2022 | 294 | 0.040 |
Why?
| | Lymphocyte Activation | 1 | 2002 | 1109 | 0.040 |
Why?
| | Anxiety | 1 | 2025 | 972 | 0.040 |
Why?
| | Cell Movement | 1 | 2002 | 948 | 0.040 |
Why?
| | Stress, Physiological | 1 | 2020 | 414 | 0.030 |
Why?
| | Feeding Behavior | 1 | 2023 | 622 | 0.030 |
Why?
| | Mice, Transgenic | 1 | 2002 | 2128 | 0.030 |
Why?
| | Sleep | 1 | 2021 | 687 | 0.030 |
Why?
| | Blood Glucose | 1 | 2024 | 2100 | 0.030 |
Why?
| | Cell Differentiation | 1 | 2002 | 1891 | 0.030 |
Why?
| | Autoantibodies | 1 | 2002 | 1468 | 0.030 |
Why?
| | Parents | 1 | 2022 | 1316 | 0.030 |
Why?
| | Pandemics | 1 | 2022 | 1491 | 0.030 |
Why?
| | Cytokines | 1 | 2021 | 2021 | 0.030 |
Why?
| | Follow-Up Studies | 1 | 2021 | 4894 | 0.020 |
Why?
| | Depression | 1 | 2021 | 1317 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2023 | 5756 | 0.020 |
Why?
| | Mice, Inbred C57BL | 1 | 2002 | 5455 | 0.020 |
Why?
| | Child | 2 | 2021 | 20884 | 0.020 |
Why?
| | Prospective Studies | 1 | 2023 | 7135 | 0.020 |
Why?
| | Cohort Studies | 1 | 2021 | 5426 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2021 | 5075 | 0.020 |
Why?
| | Infant | 1 | 2023 | 8995 | 0.020 |
Why?
| | Lymphopoiesis | 1 | 2008 | 26 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2008 | 4084 | 0.010 |
Why?
|
|
Johnson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|